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Abstract
Background: Toxic Shock Syndrome (TSS) is characterized by fever, rash, hypotension, constitutional symptoms, and multi-
organ involvement and is caused by Staphylococcus aureus enterotoxins such as Staphylococcal Enterotoxin B (SEB). SEB
binds to the MHC-IIa chain and is recognized by the TCRb chain of the Vb8 TCR+ T cells. The binding of SEB to Vb chain
results in rapid activation of T cells and production of inflammatory cytokines, such as Interleukin-2 (IL-2), Interferon-c and
Tumor Necrosis Factor-a which mediate TSS. Although IL2 was originally identified as the T cell growth factor and was
proposed to contribute to T cell differentiation, its role in TSS remains unexplored.
Methodology/Principal Findings: Mice were injected with D-Gal (25 mg/mouse). One hour after D-Galactosamine (D-Gal)
injection each mouse was injected with SEB (20 mg/mouse. Mice were then observed for 72 hrs and death was recorded at
different times. We tested Interleukin-12, IFNc, and IL-2 deficient mice (IL-22/2), but only the IL-2 deficient mice were
resistant to SEB induced toxic shock syndrome. More importantly reconstitution of IL-2 in IL-2 deficient mice restored the
shock. Interestingly, SEB induced IL-2 production from T cells was dependent on p38MAPK activation in macrophages as
inhibition of it in macrophages significantly inhibited IL-2 production from T cells.
Conclusion: This study shows the importance of IL -2 in TSS which has not been previously explored and it also shows that
regulating macrophages function can regulate T cells and TSS.
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Introduction
TSS is a superantigen-mediated disease. Superantigens are a
group of proteins (S aureus toxins in the case of TSS) that are able
to activate the immune system by bypassing certain steps in the
usual antigen-mediated immune response sequence [1]. Superan-
tigens are not processed within the antigen-presenting cell before
being presented to T cells [2], instead, they bind directly to the
alpha chain of the major histocompatibility complex, class II
(MHC-II), and are recognized by the Vb chain of T cell receptor
to trigger a massive T-cell activation [3]. Staphylococcal
Enterotoxin B (SEB), a superantigen, is among the toxins
produced by toxigenic strains of S aureus, and it can cause TSS
in a variety of settings [4]. SEB is the toxin that most commonly
causes classic food poisoning. It has also been demonstrated to
cause a non-menstrual TSS [5]. In addition, staphylococcal
infection in surgical operations can also cause TSS. It is viewed
that the mechanism of SEB-induced TSS is a massive T cell
activation [6]. While conventional antigens activate only about
0.01% to 0.1% of the T-cell population, super antigens can
activate 5%–30% of the entire T cell population [7]. Superanti-
gens lead to a rapid burst of cytokines, especially tumor necrosis
factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6 and IL-2
[8,9]. These cytokines are responsible for a capillary leak
syndrome and account for many of the clinical signs of TSS
[10]. Although TNFa and IFNc are shown to be the major players
in TSS [11], the role of IL-2 is not well studied, despite its original
identification as a T cell growth factor and its role in T cell
proliferation [12]. Therefore we compared SEB induced TSS in
BALB/c and IL-2 deficient (IL-22/2) in BALB/c background
mice. Since activation status of antigen presenting cells (APCs)
may also play a role in TSS and the crucial role of p38MAPK has
already been shown in APCs [13], we studied the role of
p38MAPK in SEB induced TSS. Our data demonstrates that IL-2
is essential for SEB induced TSS and that p38MAPK plays an
important role in the process.
Results
SEB Leads to the Activation of p38MAPK in Peritoneal
Macrophages
It was reported recently that ligation of MHC-II by LAG3 or
anti-MHC-II leads to activation of p38MAPK [14,15]. p38MAPK
has been shown to induce TNFa in the case of LPS stimulation of
macrophages systems. Since TSS is caused by TNFa, therefore we
examined the activation of p38MAPK by SEB. Macrophages were
treated with SEB for different times and we observed a time
dependent increase in p38MAPK activation (Figure 1A) peaking
at 30 mins. Similarly, cells were stimulated for 30 mins with
indicated doses of SEB and we observed a dose dependent increase
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in p38MAPK activation peaking at 2 mg/ml (Figure 1B). To
determine the effect of SB-203580 (a p38MAPK inhibitor) on the
activation of p38MAPK [16], macrophages were incubated with
SB-203580 for 2 hrs and then stimulated with SEB (2 mg/ml) for
30 mins; dose dependent inhibition of p38MAPK activation was
observed (Figure 1C). This suggests that p38MAPK is activated by
SEB in macrophages.
Inhibition of p38MAPK in Macrophages Modulates T Cell
Function
SEB binds to TCR and leads to the proliferation of T cells, and
it also signals in APCs [17]. We examined the effect of p38MAPK
inhibition in macrophages and its subsequent effect on T cell
function. Macrophages were pretreated with SB-203580 (2 mg/ml,
4 mg/ml and 8 mg/ml) for 2 hrs, washed and then were co-
cultured with CD4+ T cells. SEB (2 mg/ml) was added to the co
culture for 72 hrs, and T cell proliferation and IL-2 production
were assessed. We observed dose-dependent inhibition of T cell
proliferation and IL-2 production (Figure 2A, B). We next tested
the effect of SB-203580 on the induction of TSS. Mice were
injected with SB-203580 and subsequently challenged with a lethal
dose of SEB. Mice pretreated with SB-203580 had lower
circulating levels of TNF-a but this was not significant as
compared to circulating levels of TNF-a in untreated mice
(Figure 2c). SB203580 pretreated mice had prolonged survival as
compared to untreated controls (Figure 2d). The observation was
consistent with the incomplete protection of mice from TSS.
IL-22/2 Mice Are Resistant to SEB Induced TSS but
IL-122/2 and IFNc2/2 Mice Are Susceptible to TSS
IFNc has been implicated as one of the factors in Lipopolysac-
charide (LPS) induced shock so we checked whether IFNc2/2
mice are resistant to SEB induced TSS. Mice were challenged with
a lethal dose of SEB and mortality was observed. We observed that
IFNc mice were susceptible to SEB induced TSS. Since TSS is the
result of high inflammatory cytokine production we checked
whether IL-122/2 mice are resistant to SEB induced TSS. WT
BALB/c and IL-122/2 mice were challenged with a lethal dose of
SEB and observed for death. Much like INFc2/2 mice we found
that IL-122/2 mice were susceptible to SEB induced TSS (Fig. 3b),
suggesting that IL-12 is not involved in SEB induced TSS. Since
SEB induced IL-2 production was inhibited when SB203580-
pretreated macrophages were co-cultured with naı¨ve CD4+ T
cells, we checked TSS induction in IL-2 2/2 mice. Mice were
challenged with a lethal dose of SEB and death was recorded at
different times. We observed that IL-22/2 mice were absolutely
resistant to SEB induced TSS (Fig. 3c) suggesting that IL-2 may be
involved in SEB induced TSS.
IL-22/2 Mice Are Resistant Due to Lower TNFa
Since IL-22/2 mice are resistant to TSS, we compared
production of TNF-a in IL-22/2 and BALB/c wild type mice.
SEB-challenged mice were bled after one hour of challenge and
ELISA was done to assess circulating levels of TNFa. We found
that TNF-a was significantly less in IL-22/2 mice than that
observed in BALB/c mice (Figure 4A). We saw a higher basal level
of TNF-a in BALB/c and less IL-22/2 mice; this difference could
be due to a basal level activity of IL-2 in BALB/c mice.
Subsequently, proliferation of splenocytes was tested in wild type
and IL-22/2 mice injected with SEB. Proliferation of splenocytes
from IL-22/2 mice was found to be higher as previously described
[19] (Figure 4B). Since CD4+ T cells are responsible for the
induction of TSS [20], we wanted to know the status of CD4+ cells
in IL-22/2 mice. We performed FACS for CD4 vs. Vb8 and CD8
vs. Vb8 to check status of CD4+ T cells and CD8+ T cells from
mice injected with SEB for 2 hrs. We found no difference in the
population of CD4+T cells and CD8+ T cells (Figure 4C).
Reconstitution with rIL-2 Restores the Shock in IL-22/2
Mice
Since IL-22/2 mice were resistant to TSS, we investigated
whether reconstitution of IL-2 can restore the TNF-a production.
Splenocytes were cultured with or without rIL-2 and were
stimulated with SEB. We observed that splenocytes treated with
rIL-2 + SEB produced similar levels of TNF-a in both BALB/c
and IL-22/2 mice suggesting that rIL-2 can restore TNF-a in the
IL-22/2 splenocytes (Figure 5a). To further confirm the role of IL-
2 in SEB induced TSS, mice were injected with rIL-2 (500 ng/
mouse). Mice were then challenged with a lethal dose of SEB
Figure 1. SEB induces p38MAPK phosphorylation in peritoneal
Macrophages. (A). PMWs were stimulated for indicated times and cell
lysates were analyzed by western blotting using an anti-phospho
p38MAPK specific antibody. Equal loading was confirmed by reprobing
the stripped membrane with a p38MAPK specific antibody. (B)
Macrophages were stimulated with indicated doses of SEB and cell
lysates were analyzed by western blotting using an anti-phospho
p38MAPK specific antibody. Equal loading was confirmed by reprobing
the stripped membrane with a p38MAPK specific antibody. (C)
Macrophages were preincubated with indicated doses of SB-203580
for 2 hrs and stimulated with 2 mg/ml of SEB for 30 minutes, and then
the lysates were analyzed by western blotting against phospho
p38MAPK. Equal loading was confirmed by reprobing the stripped
membrane with a p38MAPK specific antibody.
doi:10.1371/journal.pone.0008473.g001
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(20 mg/mouse) and death was recorded at different times
(Figure 5b). We found that reconstitution of IL-2 restored the
shock in IL-22/2 mice confirming the involvement of IL-2 in SEB
induced TSS in BALB/c mice. The same mice were bled one hour
after SEB injection and ELISA was done for TNF-a. We found an
increase in TNF-a level with IL-2 reconstitution, confirming that
reconstitution of IL-2 restores TNF-a (Fig. 5c).
Discussion
SEB binds to MHC-II on APCs and to TCR on T cells producing
effects on both cell types. SEB induces IL-12 and TNF-a from APCs
and IL-2 and TNF-a from T cells [21]. TNF-a is the common
cytokine produced which then induces shock. Our study for the first
time explains the importance of signaling molecules like p38MAPK
in TSS induction. Since SEB binds to MHC class II and leads to the
activation of p38MAPK our results indicate the importance of MHC
class II signaling in the regulation of TSS. SEB induces high IL-2
production from T cells. The role of which in the induction of TSS
has not been explored. Our results show that IL-2 is involved in
induction of TSS, as IL-22/2 mice were found to be absolutely
resistant to SEB induced TSS. Interleukin-2 (IL-2) induces high
levels of IFN-c and TNF-a secretion. IL-2 induced secretion of IFN-
c and TNF-a is higher in auto graft recipients than in patients
treated by chemotherapy alone. As both TNF-a and IFNc possess
anti-leukemic and anti-infective properties, enhancement of their
secretion by IL-2 infusion after autologous bone marrow transplant
and induction after chemotherapy is of therapeutic benefit [22]. This
study reveals that mice deficient in IL-12 or IFNc are susceptible to
SEB induced TSS whereas the mice deficient in IL-2 are absolutely
resistant to SEB induced TSS. CD4+ T cells are shown to be
involved in mediating the TSS, but the mice deficient in IL-2 have
Figure 2. Macrophage pretreatment with SB-203580 inhibits SEB induced IL-2 production in T cells and imparts resistance to SEB
induced TSS in BALB/mice. (A) Peritoneal MWs were preincubated with indicated doses of SB-203580 for 2 hrs and cells were washed and then T
cells were added to these macrophage cultures these cultures were then stimulated with SEB (2 mg/ml) for 72 hours and proliferation was measured
by adding thymidine at 60 hours for 12 hours. (B) ELISA for IL-2 was done from the supernatant collected at sixty hours from above set. (C) BALB/c
mice were injected intraperitoneally (IP) with SB-203580 (25 mg/mouse) and vehicle control (DMSO) (data not shown) one hour before D-Gal injection,
then the SEB (20 mg/ml) was injected after one hour after D-Gal injection in the footpad. Mice were bled and ELISA was done to assess serum levels of
TNFa (D). Mice were then observed for mortality.
doi:10.1371/journal.pone.0008473.g002
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comparable amounts of CD4+ T cells and CD8+ T cells, which
proliferate more than WT T cells indicating that there could be some
other mechanism of TSS induction. Indeed, it is the IL-2 produced
TNF-a which causes TSS as deficiency of IL-2 reduced TNF-a in T
cells as well as in the serum of IL-2 deficient mice. Higher
proliferation of IL-2 deficient T cells was due to IL-2 induced IL-10
production from T cells, which acts as a regulatory control and
regulates T cell proliferation. This phenomenon also helps in
maintaining the homeostasis between regulatory T cells and effector
T cells. Our study shows that TNF-a plays a key role in the induction
of TSS, and complete removal of TNF-a makes the mice more
susceptible to diseases like cancer [23]. Our study shows that
deficiency of IL-2 reduces the TNF-a production but does not inhibit
it completely. This reduction in TNF-a production inhibits TSS in
mice and hence could be better a strategy to understand the
molecular mechanism of TSS.
Materials and Methods
All experiments were performed under guidelines and approval
of Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA) and Institutional Animal
Care of National Centre for Cell Science (NCCS), India and used
Committee and Institute approved protocols for the animal
experimentation.
(1) Mice and Other Reagents
SEB, purchased from Sigma (St Louis, MO) was used in all the
experiments. Antibodies anti-IL-2, anti-TNF-a, anti-CD4; anti-
Vb8 and anti-CD25 were from BD-PharMingen. Other antibod-
ies used for western blot like anti-pp38MAPK, anti-p38MAPK
were from Santa Cruz Biotechnology (Santa Cruz, CA).
Thymidine used was from BRITs (Trombay, INDIA). SB-
203580 (a p38MAPK inhibitor) was purchased from Calbiochem
(La Jolla, CA). IL-22/2, IL-122/2 and IFNc2/2 mice having
BALB/c background were purchased from Jackson Laboratories.
(2) Western Blotting
Western blots were done to determine the p38MAPK
phosphorylation. BALB/c mice were injected with 3% thiogly-
collate intraperitoneally and peritoneal macrophages (PMW) were
harvested from the peritoneum of the mice and cultured for 12 hrs
so that macrophages adhered to the plate. Cells were then washed
with RPMI alone (without FCS (Fetal Calf Serum)) to remove the
non-adherent cells. Then these cells were stimulated with SEB
(2 mg/ml) for different time periods and with different doses of
SEB and were also pretreated with a specific inhibitor of
p38MAPK in some cases. Cells were lysed with triton X 100
lysis buffer (150 mM NaCl, 25 mM Tris-Cl and 1% triton X 100
pH-7.5) and 20 mg/lane of lysates were loaded onto the gel and
blotting was done for p38MAPK phosphorylation and total
p38MAPK [15].
(3) Mortality Assay
Mice used for mortality assay [24] were BALB/c, IL-22/2
(3–4 weeks, IL-122/2 and IFNc2/2 mice (4–6 weeks), weighing
15 g–20 g each. Mice were injected with D-Gal (25 mg/mouse)
Figure 3. IL-2 knockoutmice are resistant to SEB induced TSS. (A) BALB/c and IFNc2/2mice were injected IP with D-Gal (25 mg/mouse) and after
one hour mice were injected with SEB (20 mg/mouse) in the footpad and death was recorded at indicated times. (B) IL-122/2 and BALB/c mice were
injected with D-Gal (25 mg/mouse), after one hour mice were injected with SEB (20 mg/ml) andmortality was recorded at indicated times (C) IL-22/2mice
and BALB/c mice were injected in the footpad with SEB (20 mg/mouse) one hour after D-Gal sensitization and mortality was recorded at indicated times.
doi:10.1371/journal.pone.0008473.g003
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to sensitize them to SEB induced TSS, as these mice are resistant
to TSS without D-Gal sensitization. After 1 hr of D-Gal injection,
SEB (20 mg/mouse) was injected in each mouse. Mice were then
observed for 72 hrs and death was recorded at different times.
For reconstitution & neutralization experiments rIL-2 (R&D
systems), (500 ng/mouse) was injected intraperitoneally once
only, one hour before D-Gal injection. Control mice injected with
saline.
(4) T Cell Purification
Spleens from BALB/c and IL-22/2 mice were collected and
crushed by using one end frosted slide and centrifuged at
1200 rpm for 8 minutes. Cells were treated with Gey’s solution
to lyse RBCs and then washed with RPMI+10% FCS. Then this
cell suspension was loaded onto nylon wool column to get rid of all
cells except T cells. Nylon wool column flow through was
subjected to CD4+ T cell negative selection using CD4+ T cell
isolation kit from Stem Cell Technologies (VC Canada) [25].
(5) ELISA
The ELISA for the indicated cytokines was performed
according to the manufacturers protocol (B.D. PharMingen).
(6) Serum Preparation
The control and SEB injected mice were bled and sera were
prepared after the refraction of the clots and stored at270uC until
used.
(7) Proliferation
Splenocytes were stimulated with SEB for 72 hours, thymidine
was added at the completion of 60 hours of stimulation and counts
were taken in Hewlett Packard Radioactive Scintillation counter.
(8) FACS
Mice were injected with SEB for 2 hrs and then splenocytes
were stained for CD4/CD8 vs. Vb8.
Figure 4. Low level of TNFa in IL-22/2 accounts for the resistance against SEB induced TSS. (A) IL-22/2 and BALB/c mice were bled after
one hour after SEB (20 mg/mouse) injection and circulating levels of TNFa were assessed by ELISA. (B) IL-22/2 and BALB/c mice were injected with SEB
(20 mg/mouse) in the footpad and spleens were collected after three hours from these mice. Splenocytes were prepared and cultured for 72 hours
without further stimulation and proliferation was measured. (C) Spleens were collected from IL-22/2 and BALB/c mice, splenocytes were prepared
and FACS was done for CD4 vs. Vb8 and CD8 vs. Vb8.
doi:10.1371/journal.pone.0008473.g004
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